Statistical analysis comparing the number of patients in early stages (Stage 1 and Stage 2) and those in advanced stages (Stage 3 and Stage 4) revealed that loss of FAS and/or PVR genes was not associated with NB patient stage (Table S2, Figure 4B). Here, FAS is linked to neuroblastoma.